Increased glycolytic substrate protection improves ischemic cardiac dysfunction and reduces injury-Reference-Cited by-同舟云学术

Increased glycolytic substrate protection improves ischemic cardiac dysfunction and reduces injury

Published:2000-02 Issue:2 Volume:139 Page:s107-s114
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Apstein Carl S

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference52 articles.

1. The glucose hypothesis: its relation to acute myocardial ischemia;Opie;J Mol Cell Cardiol,1970

2. Time to therapy and salvage in myocardial infarction;Milavetz;J Am Coll Cardiol,1998

3. Technetium-99m MIBI to assess coronary collateral flow during acute myocardial infarction in two closed chest animal models;Christian;J Nucl Med,1997

4. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction;Sabia;N Engl J Med,1992

5. Noninvasive prediction of residual blood flow within the risk area during acute myocardial infarction: a multicenter validation study of patients undergoing direct coronary angioplasty;Chareonthaitawee;Am Heart J,1997

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sevoflurane postconditioning attenuates cardiomyocytes hypoxia/reoxygenation injury via PI3K/AKT pathway mediated HIF-1α to regulate the mitochondrial dynamic balance;2023-07-31

2. Peritransplant Cardiometabolic and Mitochondrial Function: The Missing Piece in Donor Heart Dysfunction and Graft Failure;Transplantation;2021-02-22

3. MicroRNA‑20b‑5p promotes ventricular remodeling by targeting the TGF‑β/Smad signaling pathway in a rat model of ischemia‑reperfusion injury;International Journal of Molecular Medicine;2018-05-18

4. One‐Year Outcome of Intensive Insulin Therapy Combined to Glucose‐Insulin‐Potassium in Acute Coronary Syndrome: A Randomized Controlled Study;Journal of the American Heart Association;2017-11

5. Safety and efficacy of glucose–insulin–potassium treatment in coronary artery bypass graft surgery and percutaneous coronary intervention;Interactive CardioVascular and Thoracic Surgery;2015-08-11